Yes indeed. My take on it was positive. They used autologous CAR T therapy and the results, while statistically significant, only give patients a few more months to live. Wondering if this was the study Prendt posted about, saying it was a big threat to Imugene. Bring on Oncarlytics
IMU Price at posting:
1.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)